Current NDC auxiliary source row compounder:4091

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-1563
Product Ndc: 72934-1563
Product Ndc Digits: 729341563
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Aporix
Proprietary Name Suffix: [empty]
Nonproprietary Name: 011016 CLINDAMYCIN 1% / NIACINAMIDE 4%
Dosage Form Name: GEL
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: CLINDAMYCIN PHOSPHATE; NIACINAMIDE
Active Ingredients Info: 1 g/100 g; 4 g/100 g
History Active Ingredients Raw: CLINDAMYCIN PHOSPHATE; NIACINAMIDE
History Active Ingredients Info Raw: 1 g/100 g; 4 g/100 g
History Dosage Raw: GEL
Dea Schedule: [empty]
Package Ndc Raw: 72934-1563-2
Package Ndc: 72934-1563-2
Package Ndc Digits: 7293415632
Package Ndc11: 72934156302
Package Description: 30 g in 1 BOTTLE, PUMP (72934-1563-2)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4091
Source Row Number: 4091
Source Row Hash: 894cbf0ae420beda1875ae6f731a75e651c0d89af41962ffcb3687e2e9cf0957
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-1563",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "CLINDAMYCIN PHOSPHATE; NIACINAMIDE",
    "DOSAGEFORMNAME": "GEL",
    "NDCPACKAGECODE": "72934-1563-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Aporix",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "011016 CLINDAMYCIN 1% / NIACINAMIDE 4%",
    "PACKAGEDESCRIPTION": "30 g in 1 BOTTLE, PUMP (72934-1563-2) ",
    "ACTIVEINGREDIENTSINFO": "1 g/100 g; 4 g/100 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4091
Source Row Number: 4091
Status Scope: package
Lookup Ndc: 72934-1563-2
Lookup Ndc Digits: 7293415632
Product Ndc: 72934-1563
Product Ndc Digits: 729341563
Package Ndc: 72934-1563-2
Package Ndc Digits: 7293415632
Package Ndc11: 72934156302
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 894cbf0ae420beda1875ae6f731a75e651c0d89af41962ffcb3687e2e9cf0957
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33